UCLA Advances Precision Medicine Through Ancestrally Diverse Biobanks

Image-DNA genetic
By Nancy Osuch
1 min read

Researchers at UCLA used genetic and electronic health record data from nearly 94,000 diverse participants to uncover new ancestry specific disease risks, reveal limitations of Euro centric genetic predictions, and show that response to the drug semaglutide varies by ancestry and genetics—highlighting the value of diverse biobanks for precision medicine.

Publication:
Hass R, Margolis MP, Wei A,...Chang TS, Zaitlen N, Spellman PT, Boutros PC, Geschwind DH. Advancing Precision Health Discovery in a Genetically Diverse Health System. Cell. 2026 Mar 27:S0092-8674(26)00274-6. doi: 10.1016/j.cell.2026.03.007. PMID: 41903539 [Online ahead of print.]